Stock analysis · Bull Rankings model

TDOC analysis

Teladoc Health IncHealth Care. Scored on the same transparent model behind the daily rankings.

Digital Health
TDOC
Teladoc Health Inc · Health Care
FCF$280mC
Rev-1.5%D+
D/E0.02A
P/S0.5xA
PEG
36.7Score
$6.20$1.1B
1Y Target$8.37Model estimate · no analyst coverage
5Y Target$14.64Compound horizon
10Y Target$26.16Long-dated conviction
FCF$280mTTM · 03/26
C
FCF $280m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev-1.5%TTM YoY
D+
Revenue -1.5% — shrinking; needs a catalyst to reverse · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.02total
A
D/E 0.02 — essentially debt-free, pristine balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S0.5x
A
P/S 0.5x — deep value on sales
PEG
PEG not meaningful — earnings growth negative or data unavailable

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 36.7
Quality34.6
Growth14.4
Value99.1
Why this score
  • Diluting shareholders
Entry · Margin of safety
52-week rangeNear 52-week low
37% off the 12-month high
vs DCF fair value48% belowest. fair value ~$12
What the price assumes: free cash flow compounding at ~-17% a year for the next decade — vs the ~-2% a year our model projects from current growth and analyst estimates.

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
Health Care · market cap $1.1b. Down 37% from 52-week high of $9.89 — deep drawdown territory.
Moat
Turnaround / out-of-favor name — GAAP-unprofitable for now, so the durability case is forward-looking: it rests on a recovery (margin normalization, a cyclical upturn or restructuring) or an un-monetized asset (IP / network effects / first-mover position) rather than on current reported results.
Risk
Currently unprofitable (margin -7.1%) — path to GAAP profitability is the core thesis risk. Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Beta 2.14 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.
Horizon
1-3 yr $8.37 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $14.64 — requires the platform / technology to reach commercial scale. 10 yr $26.16 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

TDOC vs the Top Picks average

PillarTDOCBook avgDiff
Quality0.350.84-0.49
Growth0.140.87-0.73
Value0.990.76+0.23

Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.

Trend
-10.5 over 48 daily scores
From 47.2 (Jun 22) → 36.7 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Shares to buy
322
Position size
$1,996
4.0% of portfolio
Stop price
$4.65
25% below $6.20
$ at risk if stopped
$499.10
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Teladoc Health Inc (TDOC): score, valuation & FAQ

Teladoc Health Inc (TDOC) is a Health Care company that scores 36.7 out of 100 on the Bull Rankings quality-growth model — a weak reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are D/E (A) and P/S (A), while Rev (D+) rate weaker. On valuation, TDOC sits about 48% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -17% annual free-cash-flow growth over the next decade.

Is TDOC a good stock to buy?

Bull Rankings scores TDOC 36.7 out of 100 on its quality-growth model, which is a weak reading. That is driven by D/E (A) and P/S (A). A score is a quantitative screen of Teladoc Health Inc's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does TDOC score 36.7 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). TDOC earns its highest marks on D/E (A) and P/S (A), and is held back by Rev (D+). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is TDOC overvalued or undervalued?

Based on $6.20, TDOC sits about 48% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -17% annual free-cash-flow growth over the next decade. Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in TDOC?

Currently unprofitable (margin -7.1%) — path to GAAP profitability is the core thesis risk. Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Beta 2.14 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

Analyze another ticker →